Figure 1 from MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar
Diagnosis and Discussion -- Case 1068
Scientists identify the mechanisms leading to resistance to lung cancer treatment with Sotorasib, the first KRAS inhibitor - CNIO
Overcoming KRAS-Mutant Lung Cancer | American Society of Clinical Oncology Educational Book
KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer | British Journal of Cancer
Frontiers | KRAS Mutations in Squamous Cell Carcinomas of the Lung
Cancers | Free Full-Text | Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
KRAS mutant allele-specific imbalance in lung adenocarcinoma | Modern Pathology
JCI - Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas
Molecular pathways, resistance mechanisms and targeted interventions in non-small-cell lung cancer | Molecular Biomedicine
A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth | BMC Cancer | Full Text
EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer | Pharmacogenomics
KRAS Mutation Types, Statistics & Predictive Biomarkers
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth | BMC Cancer | Full Text
KRAS and MET in non-small-cell lung cancer: two of the new kids on the 'drivers' block - Juan Esteban Garcia-Robledo, Rafael Rosell, Alejandro Ruíz-Patiño, Carolina Sotelo, Oscar Arrieta, Lucia Zatarain-Barrón, Camila Ordoñez,
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
KIF13B-NRG1 Gene Fusion and KRAS Amplification in a Case of Natural Progression of Lung Cancer | Semantic Scholar
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Targeting Oncogenic Driver Mutations in Lung Cancer
Current status of lung cancer
Genetic ancestry contributes to somatic mutations in lung cancers from admixed Latin American populations | medRxiv
Cancers | Free Full-Text | Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
EGFR pathway in NSCLC. Mutations, amplification or overexpression of... | Download Scientific Diagram
Amplification of wild-type KRAS associates with elevated KRAS... | Download Scientific Diagram
KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent - Batra - 2023 - Cancer Medicine - Wiley Online Library
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition | Nature Medicine
Lung cancer - The Lancet
